EUCTR2007-005138-35-GB进行中（未招募）1 期
Triamcinolone acetonide to prevent PVR in eyes undergoing vitreoretinal surgery for open globe trauma - AOT
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •An open globe injury requiring vitrectomy either following a primary globe repair or as the primary procedure itself.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Glaucoma, ocular hypertension or steroid responsive glaucoma.
- •2) Previous vitrectomy.
- •3) Enrolment in other studies.
- •4) Inability to attend regular follow up.
- •5) Unable to give informed consent.
研究者
相似试验
已完成
不适用
Intravitreal triamcinolone acetonide combined withccataract surgery for diabetic macular edemadiabetic macular edemaJPRN-UMIN000029818Department of Ophthalmology, Mie University Graduate School of Medicine30
Unknown
4 期
IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical SteroidsVitreoretinal DiseaseOcular HypertensionNCT00744666Hotel Dieu Hospital70
已完成
不适用
Intravitreal Injection of Triamcinolone Acetonide in RetinitisIRCT201104266293N1Tehran University of Medical Sciences161
进行中（未招募）
不适用
Triamcinolone Acetonide Intravitreal Injection for the treatment for exudative maculopathy - NDexudative maculopathyMedDRA version: 8.1Level: LLTClassification code 10038862Term: Retinal exudatesEUCTR2006-001727-19-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
已完成
2 期
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema that Persists after Laser Treatment (TDMO)Diabetic Macular OedemaMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eyeACTRN12605000211662Professor Mark Gillies70